Compounded Tirzepatide is no longer available nationwide

[10/02/2024 7:04 pm EDT]

The FDA has recently removed tirzepatide, the active ingredient in medications like Mounjaro® and Zepbound®, from its drug shortage list. Due to this change, compounding pharmacies are now restricted from producing it, which means Sunrise will no longer be able to offer compounded tirzepatide prescriptions.

We understand this may be disappointing for those who have been using this more affordable option. However, we remain dedicated to helping you continue your weight loss journey with alternative treatments and a smooth transition moving forward.

Switch To Semaglutide

Switching from Compounded Tirzepatide to Semaglutide

For those who have been relying on compounded tirzepatide, we understand this update may be concerning. We're committed to providing a smooth transition to other effective weight loss treatments, including compounded semaglutide, the active ingredient in Ozempic® and Wegovy®. Your journey doesn't stop here, and we're here to help with alternative options.

Understanding the shift

Tirzepatide has been a widely used and effective choice for weight loss; however, recent updates from the FDA have led to the prohibition of compounded versions across the country. Compounding is only allowed when a medication is in shortage. With the tirzepatide shortage now fully resolved, compounding pharmacies can no longer accept or fulfill prescriptions for compounded tirzepatide.

How Does Compounded Semaglutide Differ from Compounded Tirzepatide?

Semaglutide and tirzepatide are both treatments aimed at aiding weight loss by managing appetite and influencing the body's sugar metabolism.

Semaglutide

Semaglutide mimics the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). GLP-1 is produced in the gut and regulates blood sugar levels, insulin secretion, and appetite.

GLP1s stimulate insulin secretion thereby lowering blood glucose levels. Semaglutide also reduces the secretion of glucagon, a hormone that raises blood sugar levels, leading to further blood sugar control.

Name brand Ozempic® or Wegovy®

Weekly injection starts at .25 mg, increasing every 4 weeks to 2.4 mg

Weight loss ranges from 16-18% of body weight

Starts from $129

Tirzepatide

By activating receptors, tirzepatide enhances insulin secretion and helps to lower blood glucose levels. It also reduces the release of glucagon, a hormone that raises blood sugar levels.

Tirzepatide has the additional benefit of slowing down gastric emptying, which can help regulate digestion and contribute to feelings of fullness and reduced appetite. This effect can be helpful for individuals who are aiming to manage their weight.

Name brand Mounjaro® or Zepbound®

Weekly injections start at 2.5 mg, increasing every 4 weeks to a max of 12 mg

Weight loss ranges from 18-22% of body weight per year

$149/mo service fee + copay

*Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements or address drug shortages. The FDA does not review or approve any compounded medications for safety or effectiveness. Compounded Semaglutide has not been approved by the FDA for weight loss, but studies indicate potential benefits. Results may vary.

A new kind of weight loss program

Prescription Care

If appropriate, your clinician may prescribe FDA-approved medications like GLP-1s

Insurance Coordinator

Your best in class care team helps you maximise your insurance coverage of the medications

Clinician check-ins

Meet with your board certified clinician to adjust your plan and make sure it works for you

Revolutionary medication.

FAQs

What is Ozempic®?

Ozempic is FDA-approved for the management of certain symptoms and risks of type 2 diabetes. It is used for the treatment of Type 2 Diabetes and, more recently, for chronic weight management. Ozempic is a brand-name version of the generic medication semaglutide. The technical term for these medications is "glucagon-like peptide 1 receptor agonist". These medications are called “GLP-1s” for short.

Semaglutide mimics the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). GLP-1 is produced in the gut and regulates blood sugar levels, insulin secretion, and appetite. These medications are weekly subcutaneous injections.

How much weight can I lose on Ozempic®?

In Ozempic® clinical trials, patients lost an average of 15% of their body weight*

*Patients with diabetes but with a BMI of ≥30, or ≥27 with comorbidities, lost an average of 14.9% of their body weight in 1 year in a 68-week clinical trial evaluating 1 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity.

How much does Ozempic® cost?

We navigate insurance on your behalf and are able to work with the vast majority of commercial/employer insurance plans in order to get cost-effective access for your GLP-1 medication and coverage for your labs. Lab copays vary by plan.

GLP-1s for most members with commercial insurance is typically around $25 per month after any deductible is met but, at times, and depending on plan, can be higher. Federal payors do not cover GLP-1 treatment at this time. The cost of the Sunrise program is not covered by insurance, however it is HSA/FSA eligible.

What are the potential side effects?

The medications that are a part of our platform are called GLP-1s, and are clinically-tested, stimulant-free, and non-habit forming. Side effects are extremely rare, and most individuals who take a GLP-1 do not experience any. For those who do, nausea is the most common, and this typically resolves over the first few weeks of being on the medication.

If you do experience any side effects, you’ll be able to reach out to your Medical Team directly for support. In the most recent clinical trials, less than 5% of people discontinued GLP-1 medications because of side effects.

Have more questions? Check out our Help Center